1. Bertilsson, L.: Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet,3. 128?143 (1978)
2. Christiansen, J.: Assay of carbamazepine and metabolites in plasma by quantitative thin-layer chromatography. In: Methods of analysis of antiepileptic drugs. Meijer, J. W. A., Meinardi, H., Gardner-Thorpe, C., van der Kleijn, E. (ed.), p. 87?90. New York: American Elsevier 1973
3. Christiansen, J., Dam, M.: Drug interaction in epileptic patients. In: Clinical pharmacology of antiepileptic drugs. Schneider, H., Janz, D., Gardner-Thorpe, C., Meinardi, H., Sherwin, A. L. (ed.), p. 197?199. Berlin, Heidelberg, New York: Springer 1975
4. Eichelbaum, M., Ekbom, K., Bertilsson, L., Ringberger, V. A., Rane, A.: Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur. J. Clin. Pharmacol.8, 337?341 (1975)
5. Faigle, J. W., Feldmann, K. F., Balzer, V.: Anticonvulsant effect of carbamazepine. An attempt to distinguish between the potency of the parent drug and its epoxide metabolite. In: Antiepileptic drug monitoring. Gardner-Thorpe, C., Janz, D., Meinardi, H., Pippenger, C. E. (ed.), p. 104?110. Kent, England: Pitman 1977